Table 2.
Outcome measures at baseline and posttreatment by groups.
| Outcome | Total, mean (SE) | Intervention group, mean (SE) | Control group, mean (SE) | Between-treatment differences in improvement from baseline, mean (SE) | P value | ||||||
| Dispositional anxiety | |||||||||||
|
|
Baseline | 2.22 (0.04) | 2.26 (0.06) | 2.18 (0.07) | –0.08 (0.09) | .35 | |||||
|
|
Posttreatment | 2.11 (0.04) | 2.13 (0.07) | 2.09 (0.07) | –0.04 (0.09) | .64 | |||||
|
|
Difference in difference | N/Aa | N/A | N/A | –0.04 (0.13) | .77 | |||||
| Precompetition anxiety | |||||||||||
|
|
Baseline | 1.85 (0.04) | 1.86 (0.05) | 1.83 (0.06) | 0.02 (0.08) | .79 | |||||
|
|
Posttreatment | 1.96 (0.04) | 1.98 (0.06) | 1.94 (0.06) | 0.04 (0.09) | .64 | |||||
|
|
Difference in difference | N/A | N/A | N/A | 0.02 (0.12) | .87 | |||||
| Anxiety during competition | |||||||||||
|
|
Baseline | 2.10 (0.03) | 2.10 (0.05) | 2.10 (0.05) | –0.01 (0.07) | .86 | |||||
|
|
Posttreatment | 2.19 (0.04) | 2.19 (0.05) | 2.20 (0.06) | –0.01 (0.08) | .94 | |||||
|
|
Difference in difference | N/A | N/A | N/A | –0.01 (0.10) | .93 | |||||
| FFMQb-observe | |||||||||||
|
|
Baseline | 3.08 (0.04) | 3.06 (0.06) | 3.11 (0.06) | –0.05 (0.08) | .56 | |||||
|
|
Posttreatment | 3.04 (0.04) | 3.10 (0.06) | 2.99 (0.06) | 0.11 (0.09) | .23 | |||||
|
|
Difference in difference | N/A | N/A | N/A | 0.16 (0.12) | .20 | |||||
| FFMQ-describe | |||||||||||
|
|
Baseline | 3.34 (0.04) | 3.32 (0.05) | 3.36 (0.05) | –0.04 (0.07) | .55 | |||||
|
|
Posttreatment | 3.32 (0.04) | 3.33 (0.05) | 3.30 (0.05) | 0.03 (0.07) | .74 | |||||
|
|
Difference in difference | N/A | N/A | N/A | 0.07 (0.11) | .52 | |||||
| FFMQ-aware | |||||||||||
|
|
Baseline | 3.60 (0.04) | 3.60 (0.05) | 3.60 (0.05) | –0.001 (0.07) | .89 | |||||
|
|
Posttreatment | 3.50 (0.04) | 3.51 (0.06) | 3.49 (0.06) | 0.03 (0.08) | .76 | |||||
|
|
Difference in difference | N/A | N/A | N/A | 0.04 (0.11) | .75 | |||||
| FFMQ-nonjudgmental | |||||||||||
|
|
Baseline | 3.02 (0.04) | 3.01 (0.05) | 3.04 (0.05) | –0.03 (0.07) | .71 | |||||
|
|
Posttreatment | 3.04 (0.04) | 3.01 (0.05) | 3.07 (0.05) | –0.06 (0.07) | .41 | |||||
|
|
Difference in difference | N/A | N/A | N/A | –0.03 (0.10) | .75 | |||||
| FFMQ-nonreactivity | |||||||||||
|
|
Baseline | 2.91 (0.03) | 2.91 (0.05) | 2.90 (0.05) | 0.016 (0.07) | .81 | |||||
|
|
Posttreatment | 3.08 (0.04) | 3.10 (0.05) | 3.05 (0.05) | 0.05 (0.71) | .51 | |||||
|
|
Difference in difference | N/A | N/A | N/A | 0.03 (0.10) | .75 | |||||
aN/A: not applicable.
bFFMQ: Five Facet Mindfulness Questionnaire.